nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP1A2—Carmustine—melanoma	0.0959	0.229	CbGbCtD
Perphenazine—CYP1A2—Vemurafenib—melanoma	0.0758	0.181	CbGbCtD
Perphenazine—CYP3A4—Temozolomide—melanoma	0.0725	0.173	CbGbCtD
Perphenazine—CYP2D6—Vemurafenib—melanoma	0.0625	0.149	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—melanoma	0.0581	0.139	CbGbCtD
Perphenazine—CYP3A4—Vemurafenib—melanoma	0.0397	0.095	CbGbCtD
Perphenazine—CYP3A4—Docetaxel—melanoma	0.0136	0.0326	CbGbCtD
Perphenazine—Edema cerebral—Carmustine—melanoma	0.00984	0.0701	CcSEcCtD
Perphenazine—Edema cerebral—Temozolomide—melanoma	0.0095	0.0677	CcSEcCtD
Perphenazine—Brain oedema—Carmustine—melanoma	0.00532	0.0379	CcSEcCtD
Perphenazine—Brain oedema—Temozolomide—melanoma	0.00514	0.0367	CcSEcCtD
Perphenazine—CALM2—ear—melanoma	0.00437	0.06	CbGeAlD
Perphenazine—CALM1—ear—melanoma	0.00434	0.0597	CbGeAlD
Perphenazine—HTR2A—hindlimb—melanoma	0.00274	0.0376	CbGeAlD
Perphenazine—Lupus erythematosus—Docetaxel—melanoma	0.00262	0.0187	CcSEcCtD
Perphenazine—Photosensitivity—Vemurafenib—melanoma	0.00238	0.0169	CcSEcCtD
Perphenazine—HTR2A—appendage—melanoma	0.00235	0.0323	CbGeAlD
Perphenazine—CALM2—endothelium—melanoma	0.00234	0.0321	CbGeAlD
Perphenazine—CALM1—endothelium—melanoma	0.00233	0.032	CbGeAlD
Perphenazine—CALM2—hair follicle—melanoma	0.0023	0.0316	CbGeAlD
Perphenazine—HTR7—endothelium—melanoma	0.00228	0.0313	CbGeAlD
Perphenazine—CALM2—blood vessel—melanoma	0.00216	0.0296	CbGeAlD
Perphenazine—CALM1—blood vessel—melanoma	0.00215	0.0295	CbGeAlD
Perphenazine—HTR7—blood vessel—melanoma	0.0021	0.0288	CbGeAlD
Perphenazine—CYP2C18—mammalian vulva—melanoma	0.00204	0.028	CbGeAlD
Perphenazine—Extrapyramidal disorder—Temozolomide—melanoma	0.00195	0.0139	CcSEcCtD
Perphenazine—Cholestasis—Temozolomide—melanoma	0.00194	0.0138	CcSEcCtD
Perphenazine—Eosinophilia—Vemurafenib—melanoma	0.00179	0.0127	CcSEcCtD
Perphenazine—Systemic lupus erythematosus—Docetaxel—melanoma	0.00177	0.0126	CcSEcCtD
Perphenazine—Liver injury—Temozolomide—melanoma	0.00175	0.0125	CcSEcCtD
Perphenazine—Amenorrhoea—Temozolomide—melanoma	0.00167	0.0119	CcSEcCtD
Perphenazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00165	0.0117	CcSEcCtD
Perphenazine—AOX1—eye—melanoma	0.00162	0.0223	CbGeAlD
Perphenazine—CALM2—neck—melanoma	0.00154	0.0212	CbGeAlD
Perphenazine—CALM1—neck—melanoma	0.00154	0.0211	CbGeAlD
Perphenazine—HTR7—neck—melanoma	0.0015	0.0206	CbGeAlD
Perphenazine—CALM3—eye—melanoma	0.00146	0.0201	CbGeAlD
Perphenazine—CALM3—retina—melanoma	0.00145	0.0199	CbGeAlD
Perphenazine—Oedema peripheral—Vemurafenib—melanoma	0.00142	0.0101	CcSEcCtD
Perphenazine—HTR2A—endothelium—melanoma	0.00142	0.0195	CbGeAlD
Perphenazine—HTR6—head—melanoma	0.00136	0.0187	CbGeAlD
Perphenazine—Gynaecomastia—Carmustine—melanoma	0.00136	0.0097	CcSEcCtD
Perphenazine—Throat sore—Docetaxel—melanoma	0.00136	0.00967	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Docetaxel—melanoma	0.00134	0.00958	CcSEcCtD
Perphenazine—HTR2A—blood vessel—melanoma	0.00131	0.018	CbGeAlD
Perphenazine—AOX1—mammalian vulva—melanoma	0.00129	0.0177	CbGeAlD
Perphenazine—Erythema—Vemurafenib—melanoma	0.00126	0.00896	CcSEcCtD
Perphenazine—Lethargy—Dactinomycin—melanoma	0.0012	0.00858	CcSEcCtD
Perphenazine—Nasal congestion—Temozolomide—melanoma	0.00117	0.00835	CcSEcCtD
Perphenazine—CALM3—mammalian vulva—melanoma	0.00116	0.0159	CbGeAlD
Perphenazine—CALM2—eye—melanoma	0.00115	0.0158	CbGeAlD
Perphenazine—CALM1—eye—melanoma	0.00114	0.0157	CbGeAlD
Perphenazine—CALM2—retina—melanoma	0.00114	0.0156	CbGeAlD
Perphenazine—CALM1—retina—melanoma	0.00113	0.0156	CbGeAlD
Perphenazine—Dermatitis exfoliative—Temozolomide—melanoma	0.00113	0.00806	CcSEcCtD
Perphenazine—Amenorrhoea—Docetaxel—melanoma	0.00111	0.00793	CcSEcCtD
Perphenazine—Cough—Vemurafenib—melanoma	0.0011	0.00782	CcSEcCtD
Perphenazine—Oropharyngeal pain—Docetaxel—melanoma	0.00108	0.00766	CcSEcCtD
Perphenazine—DRD2—eye—melanoma	0.00106	0.0145	CbGeAlD
Perphenazine—DRD2—retina—melanoma	0.00105	0.0144	CbGeAlD
Perphenazine—Pancytopenia—Bleomycin—melanoma	0.00104	0.0074	CcSEcCtD
Perphenazine—Ataxia—Carmustine—melanoma	0.00104	0.0074	CcSEcCtD
Perphenazine—Anaphylactic shock—Vemurafenib—melanoma	0.00103	0.00731	CcSEcCtD
Perphenazine—Dysphagia—Dactinomycin—melanoma	0.00102	0.00727	CcSEcCtD
Perphenazine—Infection—Vemurafenib—melanoma	0.00102	0.00727	CcSEcCtD
Perphenazine—DRD1—head—melanoma	0.00101	0.0139	CbGeAlD
Perphenazine—Ataxia—Temozolomide—melanoma	0.001	0.00715	CcSEcCtD
Perphenazine—CALM2—skin of body—melanoma	0.000999	0.0137	CbGeAlD
Perphenazine—CALM1—skin of body—melanoma	0.000994	0.0137	CbGeAlD
Perphenazine—Hepatocellular injury—Docetaxel—melanoma	0.000978	0.00697	CcSEcCtD
Perphenazine—Muscular weakness—Carmustine—melanoma	0.000974	0.00694	CcSEcCtD
Perphenazine—Pancytopenia—Dactinomycin—melanoma	0.000969	0.0069	CcSEcCtD
Perphenazine—Hypotension—Vemurafenib—melanoma	0.000959	0.00683	CcSEcCtD
Perphenazine—Dysphagia—Carmustine—melanoma	0.000954	0.0068	CcSEcCtD
Perphenazine—Muscular weakness—Temozolomide—melanoma	0.000941	0.00671	CcSEcCtD
Perphenazine—HTR2A—neck—melanoma	0.000936	0.0129	CbGeAlD
Perphenazine—Dysphagia—Temozolomide—melanoma	0.000922	0.00657	CcSEcCtD
Perphenazine—CALM2—mammalian vulva—melanoma	0.000911	0.0125	CbGeAlD
Perphenazine—CALM1—mammalian vulva—melanoma	0.000907	0.0125	CbGeAlD
Perphenazine—Pancytopenia—Carmustine—melanoma	0.000906	0.00646	CcSEcCtD
Perphenazine—Decreased appetite—Vemurafenib—melanoma	0.000892	0.00636	CcSEcCtD
Perphenazine—Constipation—Vemurafenib—melanoma	0.000878	0.00625	CcSEcCtD
Perphenazine—Pancytopenia—Temozolomide—melanoma	0.000876	0.00624	CcSEcCtD
Perphenazine—Hypoaesthesia—Bleomycin—melanoma	0.000871	0.00621	CcSEcCtD
Perphenazine—Hyperglycaemia—Carmustine—melanoma	0.000861	0.00614	CcSEcCtD
Perphenazine—Agranulocytosis—Dactinomycin—melanoma	0.000849	0.00605	CcSEcCtD
Perphenazine—Photosensitivity reaction—Temozolomide—melanoma	0.000842	0.006	CcSEcCtD
Perphenazine—HRH1—eye—melanoma	0.000834	0.0115	CbGeAlD
Perphenazine—Hyperglycaemia—Temozolomide—melanoma	0.000832	0.00593	CcSEcCtD
Perphenazine—Body temperature increased—Vemurafenib—melanoma	0.000811	0.00578	CcSEcCtD
Perphenazine—HTR2C—head—melanoma	0.000788	0.0108	CbGeAlD
Perphenazine—Erythema—Bleomycin—melanoma	0.000762	0.00543	CcSEcCtD
Perphenazine—Hypoaesthesia—Carmustine—melanoma	0.00076	0.00542	CcSEcCtD
Perphenazine—Hypersensitivity—Vemurafenib—melanoma	0.000756	0.00539	CcSEcCtD
Perphenazine—Oedema peripheral—Carmustine—melanoma	0.000753	0.00536	CcSEcCtD
Perphenazine—CYP2B6—skin of body—melanoma	0.000743	0.0102	CbGeAlD
Perphenazine—Hypoaesthesia—Temozolomide—melanoma	0.000735	0.00523	CcSEcCtD
Perphenazine—Oedema peripheral—Temozolomide—melanoma	0.000727	0.00518	CcSEcCtD
Perphenazine—Pruritus—Vemurafenib—melanoma	0.000726	0.00517	CcSEcCtD
Perphenazine—Lethargy—Docetaxel—melanoma	0.000724	0.00516	CcSEcCtD
Perphenazine—Erythema—Dactinomycin—melanoma	0.000711	0.00506	CcSEcCtD
Perphenazine—Diarrhoea—Vemurafenib—melanoma	0.000702	0.005	CcSEcCtD
Perphenazine—HTR2A—eye—melanoma	0.000696	0.00956	CbGeAlD
Perphenazine—HTR2A—retina—melanoma	0.00069	0.00948	CbGeAlD
Perphenazine—Leukopenia—Bleomycin—melanoma	0.000682	0.00486	CcSEcCtD
Perphenazine—Dizziness—Vemurafenib—melanoma	0.000679	0.00484	CcSEcCtD
Perphenazine—Ataxia—Docetaxel—melanoma	0.000667	0.00476	CcSEcCtD
Perphenazine—Erythema—Carmustine—melanoma	0.000665	0.00474	CcSEcCtD
Perphenazine—Cough—Bleomycin—melanoma	0.000665	0.00474	CcSEcCtD
Perphenazine—HTR1A—head—melanoma	0.000663	0.00911	CbGeAlD
Perphenazine—HRH1—mammalian vulva—melanoma	0.000662	0.00909	CbGeAlD
Perphenazine—CALM2—head—melanoma	0.000652	0.00895	CbGeAlD
Perphenazine—ADRA2A—mammalian vulva—melanoma	0.00065	0.00892	CbGeAlD
Perphenazine—CALM1—head—melanoma	0.000649	0.00891	CbGeAlD
Perphenazine—Orthostatic hypotension—Docetaxel—melanoma	0.000648	0.00462	CcSEcCtD
Perphenazine—AOX1—lymph node—melanoma	0.000645	0.00886	CbGeAlD
Perphenazine—Headache—Vemurafenib—melanoma	0.000643	0.00458	CcSEcCtD
Perphenazine—Erythema—Temozolomide—melanoma	0.000643	0.00458	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—melanoma	0.000636	0.00453	CcSEcCtD
Perphenazine—HTR7—head—melanoma	0.000634	0.00871	CbGeAlD
Perphenazine—Confusional state—Bleomycin—melanoma	0.000627	0.00447	CcSEcCtD
Perphenazine—Vision blurred—Carmustine—melanoma	0.000627	0.00447	CcSEcCtD
Perphenazine—Anaphylactic shock—Bleomycin—melanoma	0.000622	0.00443	CcSEcCtD
Perphenazine—Infection—Bleomycin—melanoma	0.000618	0.0044	CcSEcCtD
Perphenazine—Dysphagia—Docetaxel—melanoma	0.000613	0.00437	CcSEcCtD
Perphenazine—Agitation—Carmustine—melanoma	0.000611	0.00436	CcSEcCtD
Perphenazine—Vision blurred—Temozolomide—melanoma	0.000606	0.00432	CcSEcCtD
Perphenazine—DRD2—head—melanoma	0.000599	0.00823	CbGeAlD
Perphenazine—Leukopenia—Carmustine—melanoma	0.000595	0.00424	CcSEcCtD
Perphenazine—Anorexia—Bleomycin—melanoma	0.000593	0.00422	CcSEcCtD
Perphenazine—Agitation—Temozolomide—melanoma	0.000591	0.00421	CcSEcCtD
Perphenazine—Angioedema—Temozolomide—melanoma	0.000587	0.00418	CcSEcCtD
Perphenazine—Pancytopenia—Docetaxel—melanoma	0.000583	0.00415	CcSEcCtD
Perphenazine—CALM3—lymph node—melanoma	0.000581	0.00798	CbGeAlD
Perphenazine—Hypotension—Bleomycin—melanoma	0.000581	0.00414	CcSEcCtD
Perphenazine—Convulsion—Carmustine—melanoma	0.000576	0.00411	CcSEcCtD
Perphenazine—Infection—Dactinomycin—melanoma	0.000576	0.00411	CcSEcCtD
Perphenazine—Leukopenia—Temozolomide—melanoma	0.000575	0.0041	CcSEcCtD
Perphenazine—Hypertension—Carmustine—melanoma	0.000574	0.00409	CcSEcCtD
Perphenazine—Cough—Temozolomide—melanoma	0.000561	0.004	CcSEcCtD
Perphenazine—Convulsion—Temozolomide—melanoma	0.000557	0.00397	CcSEcCtD
Perphenazine—Hypertension—Temozolomide—melanoma	0.000555	0.00395	CcSEcCtD
Perphenazine—Dyspnoea—Bleomycin—melanoma	0.000554	0.00395	CcSEcCtD
Perphenazine—Anorexia—Dactinomycin—melanoma	0.000553	0.00394	CcSEcCtD
Perphenazine—Confusional state—Carmustine—melanoma	0.000547	0.0039	CcSEcCtD
Perphenazine—Decreased appetite—Bleomycin—melanoma	0.000541	0.00385	CcSEcCtD
Perphenazine—Infection—Carmustine—melanoma	0.000539	0.00384	CcSEcCtD
Perphenazine—Dry mouth—Temozolomide—melanoma	0.000535	0.00381	CcSEcCtD
Perphenazine—Jaundice—Docetaxel—melanoma	0.000533	0.0038	CcSEcCtD
Perphenazine—Pain—Bleomycin—melanoma	0.000532	0.00379	CcSEcCtD
Perphenazine—Tachycardia—Carmustine—melanoma	0.00053	0.00377	CcSEcCtD
Perphenazine—Confusional state—Temozolomide—melanoma	0.000529	0.00377	CcSEcCtD
Perphenazine—Anaphylactic shock—Temozolomide—melanoma	0.000525	0.00374	CcSEcCtD
Perphenazine—Infection—Temozolomide—melanoma	0.000521	0.00371	CcSEcCtD
Perphenazine—Anorexia—Carmustine—melanoma	0.000517	0.00369	CcSEcCtD
Perphenazine—Agranulocytosis—Docetaxel—melanoma	0.00051	0.00364	CcSEcCtD
Perphenazine—Hypotension—Carmustine—melanoma	0.000507	0.00361	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—melanoma	0.000504	0.00359	CcSEcCtD
Perphenazine—Anorexia—Temozolomide—melanoma	0.0005	0.00356	CcSEcCtD
Perphenazine—Pain—Dactinomycin—melanoma	0.000496	0.00353	CcSEcCtD
Perphenazine—Urticaria—Bleomycin—melanoma	0.000494	0.00352	CcSEcCtD
Perphenazine—Body temperature increased—Bleomycin—melanoma	0.000492	0.0035	CcSEcCtD
Perphenazine—Insomnia—Carmustine—melanoma	0.000491	0.0035	CcSEcCtD
Perphenazine—Hypoaesthesia—Docetaxel—melanoma	0.000489	0.00348	CcSEcCtD
Perphenazine—CYP2B6—head—melanoma	0.000485	0.00666	CbGeAlD
Perphenazine—Dyspnoea—Carmustine—melanoma	0.000484	0.00345	CcSEcCtD
Perphenazine—Oedema peripheral—Docetaxel—melanoma	0.000484	0.00345	CcSEcCtD
Perphenazine—Somnolence—Carmustine—melanoma	0.000483	0.00344	CcSEcCtD
Perphenazine—Insomnia—Temozolomide—melanoma	0.000474	0.00338	CcSEcCtD
Perphenazine—HRH1—head—melanoma	0.000473	0.0065	CbGeAlD
Perphenazine—Decreased appetite—Carmustine—melanoma	0.000472	0.00336	CcSEcCtD
Perphenazine—Dyspnoea—Temozolomide—melanoma	0.000468	0.00333	CcSEcCtD
Perphenazine—Somnolence—Temozolomide—melanoma	0.000466	0.00332	CcSEcCtD
Perphenazine—ADRA2A—head—melanoma	0.000465	0.00638	CbGeAlD
Perphenazine—Pain—Carmustine—melanoma	0.000464	0.00331	CcSEcCtD
Perphenazine—Constipation—Carmustine—melanoma	0.000464	0.00331	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—melanoma	0.000458	0.00327	CcSEcCtD
Perphenazine—Hypersensitivity—Bleomycin—melanoma	0.000458	0.00326	CcSEcCtD
Perphenazine—CALM2—lymph node—melanoma	0.000456	0.00627	CbGeAlD
Perphenazine—Decreased appetite—Temozolomide—melanoma	0.000456	0.00325	CcSEcCtD
Perphenazine—CALM1—lymph node—melanoma	0.000454	0.00624	CbGeAlD
Perphenazine—Pain—Temozolomide—melanoma	0.000449	0.0032	CcSEcCtD
Perphenazine—Constipation—Temozolomide—melanoma	0.000449	0.0032	CcSEcCtD
Perphenazine—Pruritus—Bleomycin—melanoma	0.00044	0.00314	CcSEcCtD
Perphenazine—Body temperature increased—Carmustine—melanoma	0.000429	0.00306	CcSEcCtD
Perphenazine—Erythema—Docetaxel—melanoma	0.000427	0.00305	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—melanoma	0.000427	0.00304	CcSEcCtD
Perphenazine—Urticaria—Temozolomide—melanoma	0.000417	0.00297	CcSEcCtD
Perphenazine—Body temperature increased—Temozolomide—melanoma	0.000415	0.00295	CcSEcCtD
Perphenazine—Muscle spasms—Docetaxel—melanoma	0.000411	0.00293	CcSEcCtD
Perphenazine—Hypersensitivity—Carmustine—melanoma	0.0004	0.00285	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—melanoma	0.000397	0.00283	CcSEcCtD
Perphenazine—HTR2A—head—melanoma	0.000395	0.00543	CbGeAlD
Perphenazine—Hypersensitivity—Temozolomide—melanoma	0.000386	0.00275	CcSEcCtD
Perphenazine—Syncope—Docetaxel—melanoma	0.000383	0.00273	CcSEcCtD
Perphenazine—Leukopenia—Docetaxel—melanoma	0.000383	0.00273	CcSEcCtD
Perphenazine—Loss of consciousness—Docetaxel—melanoma	0.000376	0.00268	CcSEcCtD
Perphenazine—Cough—Docetaxel—melanoma	0.000373	0.00266	CcSEcCtD
Perphenazine—Diarrhoea—Carmustine—melanoma	0.000371	0.00265	CcSEcCtD
Perphenazine—Pruritus—Temozolomide—melanoma	0.000371	0.00264	CcSEcCtD
Perphenazine—Convulsion—Docetaxel—melanoma	0.00037	0.00264	CcSEcCtD
Perphenazine—Hypertension—Docetaxel—melanoma	0.000369	0.00263	CcSEcCtD
Perphenazine—CYP2D6—head—melanoma	0.00036	0.00495	CbGeAlD
Perphenazine—Dizziness—Carmustine—melanoma	0.000359	0.00256	CcSEcCtD
Perphenazine—Diarrhoea—Temozolomide—melanoma	0.000359	0.00256	CcSEcCtD
Perphenazine—Dry mouth—Docetaxel—melanoma	0.000356	0.00254	CcSEcCtD
Perphenazine—Confusional state—Docetaxel—melanoma	0.000352	0.00251	CcSEcCtD
Perphenazine—Anaphylactic shock—Docetaxel—melanoma	0.000349	0.00249	CcSEcCtD
Perphenazine—Dizziness—Temozolomide—melanoma	0.000347	0.00247	CcSEcCtD
Perphenazine—Infection—Docetaxel—melanoma	0.000347	0.00247	CcSEcCtD
Perphenazine—Shock—Docetaxel—melanoma	0.000343	0.00245	CcSEcCtD
Perphenazine—Tachycardia—Docetaxel—melanoma	0.00034	0.00243	CcSEcCtD
Perphenazine—Headache—Carmustine—melanoma	0.00034	0.00242	CcSEcCtD
Perphenazine—Anorexia—Docetaxel—melanoma	0.000333	0.00237	CcSEcCtD
Perphenazine—HRH1—lymph node—melanoma	0.000331	0.00455	CbGeAlD
Perphenazine—Headache—Temozolomide—melanoma	0.000329	0.00234	CcSEcCtD
Perphenazine—Hypotension—Docetaxel—melanoma	0.000326	0.00232	CcSEcCtD
Perphenazine—ADRA2A—lymph node—melanoma	0.000326	0.00447	CbGeAlD
Perphenazine—Insomnia—Docetaxel—melanoma	0.000316	0.00225	CcSEcCtD
Perphenazine—Dyspnoea—Docetaxel—melanoma	0.000311	0.00222	CcSEcCtD
Perphenazine—Somnolence—Docetaxel—melanoma	0.00031	0.00221	CcSEcCtD
Perphenazine—Decreased appetite—Docetaxel—melanoma	0.000303	0.00216	CcSEcCtD
Perphenazine—Pain—Docetaxel—melanoma	0.000298	0.00213	CcSEcCtD
Perphenazine—Constipation—Docetaxel—melanoma	0.000298	0.00213	CcSEcCtD
Perphenazine—Body temperature increased—Docetaxel—melanoma	0.000276	0.00197	CcSEcCtD
Perphenazine—Flupentixol—ABCB1—melanoma	0.00027	0.111	CrCbGaD
Perphenazine—Hypersensitivity—Docetaxel—melanoma	0.000257	0.00183	CcSEcCtD
Perphenazine—Pruritus—Docetaxel—melanoma	0.000247	0.00176	CcSEcCtD
Perphenazine—Diarrhoea—Docetaxel—melanoma	0.000239	0.0017	CcSEcCtD
Perphenazine—Dizziness—Docetaxel—melanoma	0.000231	0.00164	CcSEcCtD
Perphenazine—Headache—Docetaxel—melanoma	0.000219	0.00156	CcSEcCtD
Perphenazine—Domperidone—ABCB1—melanoma	0.000181	0.0748	CrCbGaD
Perphenazine—Nefazodone—ABCB1—melanoma	0.000151	0.0621	CrCbGaD
Perphenazine—Triflupromazine—ABCB1—melanoma	0.000147	0.0606	CrCbGaD
Perphenazine—Acepromazine—ALB—melanoma	0.000142	0.0587	CrCbGaD
Perphenazine—Aripiprazole—ABCB1—melanoma	0.00014	0.0578	CrCbGaD
Perphenazine—Trazodone—ABCB1—melanoma	0.000139	0.0575	CrCbGaD
Perphenazine—Thioproperazine—ALB—melanoma	0.000139	0.0574	CrCbGaD
Perphenazine—Thiothixene—ALB—melanoma	0.000137	0.0565	CrCbGaD
Perphenazine—Pipotiazine—ALB—melanoma	0.000137	0.0565	CrCbGaD
Perphenazine—Fluphenazine—ABCB1—melanoma	0.000113	0.0466	CrCbGaD
Perphenazine—Clomipramine—ALB—melanoma	0.000108	0.0446	CrCbGaD
Perphenazine—Clomipramine—ABCB1—melanoma	0.000103	0.0426	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—melanoma	0.000103	0.0424	CrCbGaD
Perphenazine—Promethazine—ABCB1—melanoma	9.15e-05	0.0377	CrCbGaD
Perphenazine—Trifluoperazine—ABCB1—melanoma	9.03e-05	0.0372	CrCbGaD
Perphenazine—Quetiapine—ABCB1—melanoma	8.75e-05	0.0361	CrCbGaD
Perphenazine—Chlorpromazine—ALB—melanoma	7.42e-05	0.0306	CrCbGaD
Perphenazine—Chlorpromazine—ABCB1—melanoma	7.08e-05	0.0292	CrCbGaD
Perphenazine—CALM2—Disease—MYC—melanoma	4.39e-06	1.2e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—melanoma	4.39e-06	1.2e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.38e-06	1.2e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—melanoma	4.37e-06	1.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—melanoma	4.34e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—melanoma	4.34e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—melanoma	4.34e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—melanoma	4.34e-06	1.18e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK1—melanoma	4.33e-06	1.18e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—melanoma	4.33e-06	1.18e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK1—melanoma	4.31e-06	1.18e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—melanoma	4.31e-06	1.18e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	4.3e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—melanoma	4.3e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK1—melanoma	4.29e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK1—melanoma	4.29e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—melanoma	4.29e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—melanoma	4.29e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—melanoma	4.28e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—melanoma	4.28e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—melanoma	4.28e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—melanoma	4.25e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—melanoma	4.24e-06	1.16e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—melanoma	4.23e-06	1.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—melanoma	4.23e-06	1.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—melanoma	4.22e-06	1.15e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—melanoma	4.22e-06	1.15e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	4.2e-06	1.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—melanoma	4.19e-06	1.14e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—melanoma	4.19e-06	1.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—melanoma	4.19e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—melanoma	4.18e-06	1.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—melanoma	4.18e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—melanoma	4.17e-06	1.14e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NFKB1—melanoma	4.17e-06	1.14e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—melanoma	4.16e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—melanoma	4.15e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—melanoma	4.15e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—melanoma	4.15e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—melanoma	4.15e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—melanoma	4.12e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PRKCA—melanoma	4.12e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—melanoma	4.11e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—melanoma	4.11e-06	1.12e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—melanoma	4.11e-06	1.12e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—melanoma	4.11e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—melanoma	4.11e-06	1.12e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—melanoma	4.1e-06	1.12e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—melanoma	4.09e-06	1.12e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—melanoma	4.09e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—melanoma	4.09e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—melanoma	4.09e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ERCC2—melanoma	4.08e-06	1.11e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—melanoma	4.07e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—melanoma	4.07e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—melanoma	4.07e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—melanoma	4.06e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—melanoma	4.06e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—melanoma	4.06e-06	1.11e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—melanoma	4.05e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—melanoma	4.04e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—melanoma	4.04e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—melanoma	4.04e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—melanoma	4.03e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—melanoma	4.02e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—melanoma	4.02e-06	1.1e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK3—melanoma	4e-06	1.09e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—melanoma	3.98e-06	1.09e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—melanoma	3.96e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—melanoma	3.94e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—melanoma	3.94e-06	1.07e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK3—melanoma	3.94e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—melanoma	3.93e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—melanoma	3.93e-06	1.07e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK3—melanoma	3.93e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—melanoma	3.92e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—melanoma	3.91e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—melanoma	3.91e-06	1.07e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—melanoma	3.89e-06	1.06e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—melanoma	3.87e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—melanoma	3.86e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—melanoma	3.85e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—melanoma	3.85e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—melanoma	3.83e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—melanoma	3.83e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—melanoma	3.83e-06	1.05e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—melanoma	3.83e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—melanoma	3.82e-06	1.04e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—melanoma	3.82e-06	1.04e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK1—melanoma	3.81e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NFKB1—melanoma	3.81e-06	1.04e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—melanoma	3.81e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—melanoma	3.79e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—melanoma	3.79e-06	1.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—melanoma	3.79e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—melanoma	3.78e-06	1.03e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—melanoma	3.76e-06	1.03e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—melanoma	3.75e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—melanoma	3.75e-06	1.02e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK1—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK1—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—melanoma	3.74e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—melanoma	3.73e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—melanoma	3.73e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—melanoma	3.73e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—melanoma	3.73e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—melanoma	3.73e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—melanoma	3.72e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—melanoma	3.72e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—melanoma	3.71e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—melanoma	3.71e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—melanoma	3.71e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—melanoma	3.7e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—melanoma	3.7e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—melanoma	3.69e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NFKB1—melanoma	3.68e-06	1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NFKB1—melanoma	3.68e-06	1e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—melanoma	3.67e-06	1e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—melanoma	3.64e-06	9.93e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—melanoma	3.63e-06	9.9e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—melanoma	3.62e-06	9.88e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—melanoma	3.61e-06	9.85e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—melanoma	3.61e-06	9.85e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—melanoma	3.59e-06	9.81e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK3—melanoma	3.58e-06	9.78e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—melanoma	3.57e-06	9.76e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—melanoma	3.57e-06	9.76e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—melanoma	3.57e-06	9.76e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—melanoma	3.56e-06	9.73e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—melanoma	3.55e-06	9.69e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—melanoma	3.54e-06	9.66e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—melanoma	3.54e-06	9.65e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—melanoma	3.53e-06	9.64e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—melanoma	3.48e-06	9.51e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—melanoma	3.48e-06	9.5e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—melanoma	3.46e-06	9.45e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—melanoma	3.45e-06	9.43e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—melanoma	3.45e-06	9.41e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—melanoma	3.45e-06	9.41e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—melanoma	3.42e-06	9.34e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—melanoma	3.41e-06	9.31e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—melanoma	3.41e-06	9.31e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—melanoma	3.41e-06	9.31e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK1—melanoma	3.41e-06	9.3e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—melanoma	3.41e-06	9.3e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—melanoma	3.34e-06	9.12e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—melanoma	3.34e-06	9.12e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—melanoma	3.33e-06	9.09e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—melanoma	3.31e-06	9.05e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—melanoma	3.31e-06	9.05e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—melanoma	3.31e-06	9.03e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—melanoma	3.31e-06	9.03e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—melanoma	3.3e-06	9.02e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—melanoma	3.3e-06	9.01e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—melanoma	3.3e-06	9.01e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—melanoma	3.3e-06	9.01e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—melanoma	3.3e-06	9.01e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—melanoma	3.3e-06	9e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—melanoma	3.3e-06	9e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK3—melanoma	3.27e-06	8.92e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—melanoma	3.27e-06	8.92e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—melanoma	3.25e-06	8.87e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—melanoma	3.24e-06	8.85e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—melanoma	3.24e-06	8.84e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—melanoma	3.23e-06	8.81e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—melanoma	3.22e-06	8.8e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—melanoma	3.22e-06	8.79e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—melanoma	3.2e-06	8.74e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—melanoma	3.19e-06	8.72e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—melanoma	3.18e-06	8.68e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—melanoma	3.17e-06	8.66e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK3—melanoma	3.16e-06	8.63e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK3—melanoma	3.16e-06	8.63e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—melanoma	3.15e-06	8.59e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—melanoma	3.14e-06	8.58e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—melanoma	3.14e-06	8.56e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—melanoma	3.12e-06	8.52e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—melanoma	3.12e-06	8.52e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—melanoma	3.11e-06	8.5e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK1—melanoma	3.11e-06	8.49e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—melanoma	3.11e-06	8.49e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—melanoma	3.07e-06	8.39e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—melanoma	3.07e-06	8.39e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—melanoma	3.07e-06	8.39e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—melanoma	3.06e-06	8.35e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—melanoma	3.06e-06	8.34e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—melanoma	3.04e-06	8.31e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—melanoma	3.04e-06	8.31e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK1—melanoma	3.01e-06	8.21e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK1—melanoma	3.01e-06	8.21e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—melanoma	3.01e-06	8.21e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—melanoma	3.01e-06	8.21e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—melanoma	3.01e-06	8.21e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—melanoma	3e-06	8.19e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.96e-06	8.07e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—melanoma	2.94e-06	8.02e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—melanoma	2.92e-06	7.98e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—melanoma	2.89e-06	7.89e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—melanoma	2.88e-06	7.86e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—melanoma	2.87e-06	7.84e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—melanoma	2.86e-06	7.81e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—melanoma	2.84e-06	7.75e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—melanoma	2.84e-06	7.75e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—melanoma	2.83e-06	7.74e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—melanoma	2.81e-06	7.66e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—melanoma	2.8e-06	7.64e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—melanoma	2.77e-06	7.55e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.74e-06	7.47e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—melanoma	2.71e-06	7.39e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—melanoma	2.7e-06	7.37e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—melanoma	2.7e-06	7.36e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—melanoma	2.65e-06	7.25e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—melanoma	2.65e-06	7.23e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—melanoma	2.64e-06	7.2e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—melanoma	2.62e-06	7.15e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—melanoma	2.61e-06	7.12e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—melanoma	2.61e-06	7.12e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—melanoma	2.61e-06	7.12e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—melanoma	2.55e-06	6.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—melanoma	2.55e-06	6.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—melanoma	2.52e-06	6.89e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—melanoma	2.52e-06	6.89e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—melanoma	2.5e-06	6.84e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—melanoma	2.5e-06	6.81e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—melanoma	2.47e-06	6.75e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—melanoma	2.45e-06	6.68e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—melanoma	2.42e-06	6.59e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—melanoma	2.41e-06	6.59e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—melanoma	2.41e-06	6.59e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—melanoma	2.39e-06	6.52e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—melanoma	2.31e-06	6.31e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—melanoma	2.31e-06	6.31e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—melanoma	2.3e-06	6.29e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—melanoma	2.29e-06	6.26e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—melanoma	2.28e-06	6.24e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—melanoma	2.2e-06	6.02e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—melanoma	2.14e-06	5.83e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—melanoma	2.13e-06	5.82e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—melanoma	2.13e-06	5.82e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—melanoma	2.05e-06	5.59e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—melanoma	1.95e-06	5.33e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—melanoma	1.88e-06	5.14e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—melanoma	1.87e-06	5.09e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—melanoma	1.59e-06	4.35e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—melanoma	1.51e-06	4.11e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—melanoma	1.23e-06	3.36e-06	CbGpPWpGaD
